Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03038490
Other study ID # KW/FR-16-167(104-04)
Secondary ID
Status Recruiting
Phase N/A
First received January 28, 2017
Last updated January 30, 2017
Start date December 1, 2016
Est. completion date March 31, 2020

Study information

Verified date January 2017
Source Our Lady of Maryknoll Hospital
Contact Kwok Man Lo, FHKAM (Med)
Email lokm1@ha.org.hk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To investigate whether an oral nutritional supplement of a mixture of arginine, glutamine and HMB for a maximum period of four weeks is more beneficial than the standard dietary approach to the healing of pressure ulcers, and to examine whether the use of it can reduce admissions and length of hospitalizations for these patients.


Description:

All patients would be assessed by a dietitian to ensure them receiving nutritional support of at least 30 kcal/kg/day and of at least 1.2 g/kg/day of protein regardless of feeding method. During the study period, vitamin C and zinc supplement would not be given. Nutritional supplement other than that provided by the dietitian to meet the energy and protein requirement would not be given. The pressure ulcers would be cared according to the "Basic nursing standards for patient care: Wound dressing - Version 5" published by the Hospital Authority Head Office.

The treatment group would also be given 2 Sackets of a mixture of arginine, glutamine and HMB (ABOUND) every day for a maximum period of 4 weeks, either orally or via enteral feeding.


Recruitment information / eligibility

Status Recruiting
Enrollment 90
Est. completion date March 31, 2020
Est. primary completion date September 30, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Inpatients of medical and geriatric wards of OLMH and WTSH

2. Aged 18 and older with stage III - IV lesions

3. Patients fed orally or through feeding tubes were included

Exclusion Criteria:

1. Patients with history of using the nutritional supplement (ABOUND) in previous three months

2. Patients with cellulitis, wounds with purulent discharge or osteomyelitis or sepsis

3. Patients requiring protein restriction

4. Patients with poorly controlled diabetes mellitus (latest HbA1C > 8.5) (healing process may be affected

5. Patients under palliative care

Study Design


Intervention

Dietary Supplement:
ABOUND
an oral mixture of arginine, glutamine and beta-hydroxy-beta-methylbutyrate

Locations

Country Name City State
Hong Kong Our Lady of Maryknoll Hospital Wong Tai Sin

Sponsors (2)

Lead Sponsor Collaborator
Our Lady of Maryknoll Hospital Wong Tai Sin Hospital

Country where clinical trial is conducted

Hong Kong, 

References & Publications (3)

Cereda E, Gini A, Pedrolli C, Vanotti A. Disease-specific, versus standard, nutritional support for the treatment of pressure ulcers in institutionalized older adults: a randomized controlled trial. J Am Geriatr Soc. 2009 Aug;57(8):1395-402. doi: 10.1111/j.1532-5415.2009.02351.x. — View Citation

Cereda E, Klersy C, Serioli M, Crespi A, D'Andrea F; OligoElement Sore Trial Study Group.. A nutritional formula enriched with arginine, zinc, and antioxidants for the healing of pressure ulcers: a randomized trial. Ann Intern Med. 2015 Feb 3;162(3):167-74. doi: 10.7326/M14-0696. Erratum in: Ann Intern Med. 2015 Dec 15;163(12):964. — View Citation

Wong A, Chew A, Wang CM, Ong L, Zhang SH, Young S. The use of a specialised amino acid mixture for pressure ulcers: a placebo-controlled trial. J Wound Care. 2014 May;23(5):259-60, 262-4, 266-9. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary percentage change in pressure ulcer area 4 weeks
Primary change in Pressure Ulcer Scale for Healing (PUSH) 4 weeks
Secondary number of hospital admissions six months
Secondary length of hospitalisation six months
See also
  Status Clinical Trial Phase
Completed NCT04311229 - Effectiveness of Negative-Pressure Wound Therapy N/A
Recruiting NCT05894291 - Comparaison of Two Prone Position Techniques on Occurence of Pressure Sores in ICU N/A
Completed NCT02222454 - Safety Evaluation of the KLOX BioPhotonic System in Stage II and III Pressure Ulcers N/A
Not yet recruiting NCT05649332 - Study to Evaluate the Performance and Safety of the Medical Device Argogen N/A
Completed NCT05130814 - EmoLED Medical Device Treatment of Second and Third Stage Pressure Ulcers N/A
Recruiting NCT05496296 - Comparison of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2, 3 and 4 Pressure Injuries N/A
Completed NCT03283787 - Comparing Concomitant Use of ACell MicroMatrix® and ACell Cytalâ„¢ to Standard of Care in Stage 3 or 4 Pressure Injuries N/A